Purchases and Sales Made in Q4 2022 in Can Fite Bio Pharma Ltd. (CANF)
This table provides information about the institutional ownership of Can Fite Bio Pharma Ltd. (CANF) during Q4 2022. The information is specifically focused on institutions that hold shares of Can-Fite BioPharma Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
12.4K+ 85.16% |
$7.45K - $111K
|
27K
$54.2K
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-8.65K- 49.82% |
$5.19K - $77.3K
|
8.71K
$17.5K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-15.5K- 4.84% |
$9.3K - $139K
|
305K
$612K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-26.6K- 44.86% |
$16K - $238K
|
32.7K
$65.8K
|